Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

PRMT5 Is Required for Lymphomagenesis Triggered by Multiple Oncogenic Drivers

Open access

Published version of a preprint

Abstract

UNLABELLED: Protein arginine methyltransferase 5 (PRMT5) has been implicated as a key modulator of lymphomagenesis. Whether PRMT5 has overt oncogenic function in the context of leukemia/lymphoma and whether it represents a therapeutic target remains to be established. We demonstrate that inactivation of PRMT5 inhibits colony-forming activity by multiple oncogenic drivers, including cyclin D1, c-MYC, NOTCH1, and MLL-AF9. Furthermore, we demonstrate that PRMT5 overexpression specifically cooperates with cyclin D1 to drive lymphomagenesis in a mouse model, revealing inherent neoplastic activity. Molecular analysis of lymphomas revealed that arginine methylation of p53 selectively suppresses expression of crucial proapoptotic and antiproliferative target genes, thereby sustaining tumor cell self-renewal and proliferation and bypassing the need for the acquisition of inactivating p53 mutations. Critically, analysis of human tumor specimens reveals a strong correlation between cyclin D1 overexpression and p53 methylation, supporting the biomedical relevance of this pathway. SIGNIFICANCE: We have identified and functionally validated a crucial role for PRMT5 for the inhibition of p53-dependent tumor suppression in response to oncogenic insults. The requisite role for PRMT5 in the context of multiple lymphoma/leukemia oncogenic drivers suggests a molecular rationale for therapeutic development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-14-0625

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Cited by

See all 145

Metadata

Authors
Li, Y., Chitnis, N., Nakagawa, H., Kita, Y., Natsugoe, S., Yang, Y., Li, Z., Wasik, M., Klein-Szanto, A. J. P., Rustgi, A. K., & Diehl, J. A.
Affiliations
  • University of Pennsylvania (US)
  • Abramson Cancer Center (US)
  • Kagoshima University (JP)
  • Medical University of South Carolina (US)
  • 7Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Corresponding author
Diehl, J. Alan
Venue
Cancer Discovery
Published
2015-03-01
Volume
5
Issue
3
Pages
288-303
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W2137003359
Cited by
143
References
49
Citations by year
2026: 3 · 2025: 8 · 2024: 9 · 2023: 11 · 2022: 19 · 2021: 13 · 2020: 15 · 2019: 18 · 2018: 17 · 2017: 12 · 2016: 12 · 2015: 6
FWCI
6.80
Type
journal article
Language
en
Open access
Locations
  • Cancer Discovery (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Cancer Institute (P01CA098101, CA11360, R01CA093237)
  • National Institute of Allergy and Infectious Diseases (R01AI070603)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK050306)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
Keywords
PRMT5, protein arginine methyltransferase, lymphomagenesis, cyclin D1, c-Myc, Notch1, MLL-AF9, leukemia, lymphoma, tumor self-renewal, therapeutic target
MeSH terms
Animals, Arginine, Cell Transformation, Neoplastic, Enzyme Activation, Humans, Lymphoma, Methylation, Mutation, Oncogenes, Phosphorylation, Protein-Arginine N-Methyltransferases, Transcription Factors, Leukemia, T-Cell, Cluster Analysis, Tumor Suppressor Protein p53, Lymphoma, T-Cell, Apoptosis, Cyclin D1, Amino Acid Substitution, Gene Expression Profiling, Adaptor Proteins, Signal Transducing, Cyclin-Dependent Kinase 4, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PRMT5 Is Required for Lymphomagenesis Triggered by Multiple Oncogenic Drivers. https://app.cochat.ai/papers/10.1158/2159-8290.cd-14-0625
The paper
Li, Y., Chitnis, N., Nakagawa, H., Kita, Y., Natsugoe, S., Yang, Y., Li, Z., Wasik, M., Klein-Szanto, A. J. P., Rustgi, A. K., & Diehl, J. A. (2015). PRMT5 Is Required for Lymphomagenesis Triggered by Multiple Oncogenic Drivers. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-14-0625

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.